DBCCR1 mediates death in cultured bladder tumor cells

Oncogene

Volumn 23, Issue 1, 2004, Pages 82-90

  Wright, Kate O ^a   Messing, Edward M ^a   Reeder, Jay E ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Bladder neoplasm; Chromosme 9; DBCCR1; Tumor suppressor gene

Indexed keywords

CASPASE 3; DELETED IN BLADDER CANCER CHROMOSOME REGION 1 PROTEIN; GREEN FLUORESCENT PROTEIN; PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLADDER TUMOR; CANCER CELL DESTRUCTION; CELL DEATH; CELL LINE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; CYTOPLASM; DNA STRAND BREAKAGE; ENZYME ACTIVATION; EXPRESSION VECTOR; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; IN SITU NICK-END LABELING; MICE; NIH 3T3 CELLS; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

ANIMALIA; VECTORS;

EID: 0942279491     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206642     Document Type: Article

References (25)

1. Cairns P, Shaw M and Knowles M. (1993). Oncogens, 8, 1083.
2. Compton M. (1992). Cancer Metastasis Rev., 2, 105-119.
3. Creagh E and Martin S. (2001). Biochem. Soc. Trans., 29.
4. Devlin J, Keen AJ and Knowles M. (1994). Oncogene, 9, 2757-2760.
5. Easton R, Deckwerth T, Parsadanian A and Johnson E. (1997). J. Neurosci., 17, 9656-9666.
6. Fujiwara H, Emi M, Nagai H, Ohgaki K, Imoto I, Akimoto M, Ogawa O and Habuchi T. (2001). J. Hum. Genet., 46, 372-377.
7. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W and Bujard H. (1995). Science, 268, 1766-1769.
8. Groger RK, Morrow DM and Tykocinski ML. (1989). Gene, 81, 285-294.
9. Habuchi T, Luscombe M, Elder P and Knowles M. (1998). Genomics, 48, 277-288.
10. Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, Satoh S, Akao T, Sato K, Ogawa O, Knowles M and Kata T. (2001). Oncogene, 20, 531-537.
11. Habuchi T, Yoshida O and Knowles M. (1997). Hum. Mol. Genet., 6, 913-919.
12. Howard C, Claudio P, De Luca A, Stiegler P, Jori F, Safdar N, Caputi M, Khalili K and Giordano A. (2000). Cancer Res., 60, 2737-2744.
13. Kaufmann S and Hengartner M. (2001). Trends Cell Biol., 12, 526-534.
14. Keen A and Knowles M. (1994). Oncogens, 9, 2083-2088.
15. Leist M and Jaattela M. (2001). Nat. Rev., 2, 1-10.
16. Li W, Fan J, Hochhauser D and Bertino J. (1997). Cancer Res., 57, 2193-2199.
17. Mickey D, Mickey G, Murphy W, Niell H and Soloway M. (1982). J. Urol., 27, 23307.
18. Nicholson D and Thornberry N. (1997). Trends Biochem. Sci., 22, 299-306.
19. Nishiyama H, Gill J, Pitt E, Kennedy W and Knowles M. (2001). Oncogene, 20, 2956-2964.
20. Nishiyama H, Takahashi T, Kakehi Y, Habuchi T and Knowles M. (1999). Genes, Chromsomes, Cancer, 26, 171-175.
21. Ruppert J, Tokino K and Sidransky D. (1993). Cancer Res., 53, 5093-5095.
22. Sowden M, Eagleton M and Smith H. (1998). Nucleic Acids Res., 26, 1644-1652.
23. Stadler W, Steinberg G, Yang X, Hagos F, Turner C and Olopade O. (2001). Clin. Cancer Res., 7, 1676-1682.
24. Tang D and Porter A. (1996). Pathol. Oncol. Res., 2, 117-131.
25. Weng L, Smith W, Dahia P, Ziebold U, Gil E, Lees J and Eng C. (1999). Cancer Res., 59, 5808-5814.